Mercer Global Advisors’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-10,860
Closed -$98K 1144
2019
Q4
$98K Sell
10,860
-6,780
-38% -$55.1K ﹤0.01% 1124
2019
Q3
$126K Buy
17,640
+7,148
+68% +$51.3K ﹤0.01% 1067
2019
Q2
$83K Sell
10,492
-2,405
-19% -$28.5K ﹤0.01% 1108
2019
Q1
$162K Buy
+12,897
New +$204K 0.01% 999

Other funds holding EVH

Mercer Global Advisors's EVH Position: Q1 2020 in Review

Mercer Global Advisors sold out of Evolent Health (EVH) in Q1 2020, closing a stake of 10,860 shares — an estimated $98K sold.

Mercer Global Advisors first reported a position in EVH in Q1 2019 and held it in 4 quarters. The position peaked at $162K in Q1 2019. 154 funds tracked by Wall St. Rank hold EVH as of Q1 2020.

  • Mercer Global Advisors reported no remaining Evolent Health position as of Q1 2020 after selling out during the quarter.
  • Mercer Global Advisors sold 10,860 Evolent Health shares in Q1 2020, an estimated $98K.
  • Mercer Global Advisors first reported a position in Evolent Health in Q1 2019 and held it in 4 quarters.
  • Mercer Global Advisors's Evolent Health position peaked at $162K in Q1 2019.
  • 154 funds tracked by Wall St. Rank held Evolent Health as of Q1 2020.

Based on Mercer Global Advisors's 13F filing for Q1 2020, filed 18 May 2020.